Identity data, precision instruments, insulin pumps, insurance and freight rail — five names moving on five very different catalysts today.
Red Violet sells data tools that help businesses confirm who someone really is, and demand for that has never been hotter as fraud losses mount. The next read is how it spends a freshly raised war chest.
View Chart →Ralliant makes the precision instruments engineers use to test electronics, and after a long slump that business is finally accelerating again. Watch whether momentum holds as it laps its spinoff year.
View Chart →Beta Bionics makes an insulin pump that decides every dose on its own, and it just began a trial to bring that to type 2 diabetes, a far bigger market. The whole story now rests on FDA timing for its patch pump.
View Chart →Prudential sells insurance and retirement products, but the growth story now sits with its asset management arm, PGIM, as the company shifts toward capital-light businesses. Watch whether the pivot keeps lifting earnings.
View Chart →Wabtec builds the locomotives and braking systems that keep freight rail moving, and its order backlog has swelled to record size on big international wins. Management promised the biggest margin gains come late this year.
View Chart →This newsletter is for informational purposes only and does not constitute financial advice. TradersPro and its contributors are not registered investment advisors. Always conduct your own due diligence before making investment decisions. Past performance is not indicative of future results.
